Diana Antoniskis
About
In The Last Decade
Diana Antoniskis
20 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Infectious Diseases 1.1k
- Epidemiology 964
- Surgery 351
- Virology 290
- Parasitology 248
Countries citing papers authored by Diana Antoniskis
This map shows the geographic impact of Diana Antoniskis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Antoniskis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Antoniskis more than expected).
Fields of papers citing papers by Diana Antoniskis
This network shows the impact of papers produced by Diana Antoniskis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Antoniskis. The network helps show where Diana Antoniskis may publish in the future.
Co-authorship network of co-authors of Diana Antoniskis
This figure shows the co-authorship network connecting the top 25 collaborators of Diana Antoniskis. A scholar is included among the top collaborators of Diana Antoniskis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Antoniskis. Diana Antoniskis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 81 | |
| 2 | 29 | |
| 3 | 5 | |
| 4 | 222 | |
| 5 | 14 | |
| 6 | 3 | |
| 7 | 31 | |
| 8 | 293 | |
| 9 | Relationship of the Manifestations of Tuberculosis to CD4 Cell Counts in Patients with Human Immunodeficiency Virus Infection breakdown → | 436 |
| 10 | 12 | |
| 11 | 10 | |
| 12 | 15 | |
| 13 | An open-label, dose-ranging trial of AL 721 in patients with persistent generalized lymphadenopathy and AIDS-related complex. | 4 |
| 14 | 31 | |
| 15 | 39 | |
| 16 | 136 | |
| 17 | 249 | |
| 18 | 20 | |
| 19 | 14 | |
| 20 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.